FRONTLINE HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS STEM-CELL SUPPORT (ASCT) IN YOUNG PTS WITH DISSEMINATED INTERMEDIATE OR HIGH-GRADE LYMPHOMAS - EVALUATION OF FEASIBILITY AND EFFICACY IN CONSECUTIVE PROSPECTIVE TRIALS
N. Milpied et al., FRONTLINE HIGH-DOSE THERAPY (HDT) WITH AUTOLOGOUS STEM-CELL SUPPORT (ASCT) IN YOUNG PTS WITH DISSEMINATED INTERMEDIATE OR HIGH-GRADE LYMPHOMAS - EVALUATION OF FEASIBILITY AND EFFICACY IN CONSECUTIVE PROSPECTIVE TRIALS, British Journal of Haematology, 102(1), 1998, pp. 237-237